Menu

Trending event

Konstantin Linnik moderates The Capital Network’s “Developing an Effective IP Strategy: From an Idea to Blockbuster Science”

Print PDF
02.18.2014

Konstantin Linnik, a partner in the Intellectual Property Department and a member of the firm’s Life Sciences practice group, served as a moderator at The Capital Network’s (TCN) lunch program “Developing an Effective IP Strategy: From an Idea to Blockbuster Science” on February 18. The program focused on in-licensing technology; what to expect in investors’ and pharma partners’ diligence; balancing disclosure, ownership, enablement and obviousness in charting out an IP strategy; how to properly project costs and maximize ROI; how to factor in regulatory exclusivities, patent linkage and extensions; and the major legal differences between biological and chemical entities.

For more information, click here.

More Events >